Investigating the Impact of the Prehospital Administration of Tranexamic Acid on Traumatic Brain Injury Patients, a systematic review
| dc.contributor.advisor | Dr. Zubair Ahmed | |
| dc.contributor.author | MAJED FAHAD ABDULLAH ALOBAID | |
| dc.date | 2021 | |
| dc.date.accessioned | 2022-05-29T10:47:10Z | |
| dc.date.available | 2022-05-29T10:47:10Z | |
| dc.degree.department | Trauma Sciences | |
| dc.degree.grantor | Medical School, University of Birmingham | |
| dc.description.abstract | Background ABSTRACT Tranexamic acid (TXA) is an Antifibrinolytic agent and time-dependent drug that increases positive outcomes when used within the first three hours after an injury. TXA is administered to traumatic brain injury (TBI) patients in a pre-hospital setting to stabilise and prevent intracranial haemorrhage. A systematic review was conducted to investigate the impacts of pre-hospital administration of TXA in TBI patients. | |
| dc.identifier.uri | https://drepo.sdl.edu.sa/handle/20.500.14154/45705 | |
| dc.language.iso | en | |
| dc.title | Investigating the Impact of the Prehospital Administration of Tranexamic Acid on Traumatic Brain Injury Patients, a systematic review | |
| sdl.thesis.level | Master | |
| sdl.thesis.source | SACM - United Kingdom |